Table 3.
Comparability of the Tests with Global Initiative for Asthma Criteria
| Cutofflevel | Comparability with GINA |
κa | P | ||
|---|---|---|---|---|---|
| Not well-controlled asthma, n (%)* | Well-controlled asthma, n (%)* | ||||
| FeNO | >35 ppb | 2 (6.1) | 162 (83.1) | −0.106 | 0.109 |
| FeNO | >20 ppb | 15 (14.4) | 96 (84.2) | −0.014 | 0.779 |
| PACT | <22 | 15 (23.1) | 78 (97.5) | 0.221 | <0.001 |
| ACT | <21 | 17 (48.6) | 45 (95.8) | 0.473 | <0.001 |
| PAQLQ | <5.9 | 29 (27.9) | 110 (94.8) | 0.150 | <0.001 |
| FEV1 | <80% | 6 (27.3) | 160 (85.6) | 0.105 | 0.118 |
| FEV1/FVC | <0.80 | 0 (0.0) | 173 (84.0) | −0.027 | 0.450 |
| FEF25–75 | <80% | 9 (15.5) | 127 (84.1) | −0.004 | 0.947 |
Statistically significant results were written in bold.
*
Percents of row.
a
kappa test.
ACT/pACT, asthma control test/pediatric asthma control test; FEF25–75, forced expiratory flow at 25% to 75% of forced vital capacity; FeNO, fractional exhaled nitric oxide; FEV1, forced expiratory volume in 1 s; FEV1/FVC, the ratio of “forced expiratory volume in 1 s” to “forced vital capacity”; GINA, Global Initiative for Asthma; PAQLQ, Pediatric Asthma Quality of Life Questionnaire.